Director/PDMR Shareholding

30 Mar 2009 10:11



30 March 2009

GW Pharmaceuticals plc("GW" or "the Company")

SCHEDULE 11 

NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 

Mr David Kirk, a Director of the Company, has today notified the Company that on 27th March 2009 he and his wife each purchased 6,750 ordinary shares of 0.1 pence each in the Company. In total 13,500 shares were purchased at an average price of 64.1p per share. 

Following this transaction Mr David Kirk has a beneficial interest in 19,500 ordinary shares, amounting to 0.02% of the voting rights of the Company.

Enquiries: 

GW Pharmaceuticals plc 01980 557000

Adam George, Company Secretary